HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
Related Research units
Abstract
To reassess the effect of modafinil, a wakefulness-promoting artificial psychostimulant, on fatigue and neuropsychological measures in patients with multiple sclerosis.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 8 |
| ISSN | 1352-4585 |
| Publication status | Published - 2011 |
| pubmed | 21561959 |
|---|
